title: Clot stability and fibrin deposition is strongly reduced in mice in which mouse TAFI is replaced by human TAFI.
authors.affiliation: Laboratory for Therapeutic and Diagnostic antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
authors.forename: Niraj
authors.initials: N
authors.lastname: Mishra
authors.affiliation: Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; Department of Plasma Proteins, Sanquin, Amsterdam, the Netherlands.
authors.forename: Joost C M
authors.initials: JC
authors.lastname: Meijers
authors.affiliation: Laboratory for Therapeutic and Diagnostic antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Declerck
authors.affiliation: Laboratory for Therapeutic and Diagnostic antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Electronic address: ann.gils@pharm.kuleuven.be.
authors.forename: Ann
authors.initials: A
authors.lastname: Gils
mesh_terms: D000818:Animals; D001777:Blood Coagulation / Q000502:physiology*; D025901:Carboxypeptidase B2 / Q000097:blood* / Q000235:genetics; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout
chemical_list: D005337:Fibrin; D025901:Carboxypeptidase B2